Sarah E Ackermann

5PUBLICATIONS
116CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 09, 2026
Acquisition of Resistance to RAS Inhibition Is Associated with the Upregulation of Macropinocytosis through Both PI3K-Dependent and -Independent Signaling.

|Jun 26, 2026
Patient-derived organoids across cancers reveal conserved tumor heterogeneity and actionable therapeutic vulnerabilities.

|Nov 17, 2025
CRISPR-Cas9 Screening Identifies Resistance Mechanisms to KRAS Inhibition in Pancreatic Cancer.

Szu-Aun Long, Haley Todd, Grace Goodhart

|Feb 11, 2025
Concurrent Inhibition of the RAS-MAPK Pathway and PIKfyve Is a Therapeutic Strategy for Pancreatic Cancer.

Jonathan M DeLiberty, Mallory K Roach, Clint A Stalnecker

|Feb 01, 2025
Kinome-Focused CRISPR-Cas9 Screens in African Ancestry Patient-Derived Breast Cancer Organoids Identify Essential Kinases and Synergy of EGFR and FGFR1 Inhibition.

Florencia P Madorsky Rowdo, Rachel Martini, Sarah E Ackermann

Pageof 1

Frequent Collaborators

3 joint publications

Clint A Stalnecker

3 joint publications

Adrienne D Cox

3 joint publications

Kirsten L Bryant

2 joint publications

Olivier Elemento